FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
THE THERATEST EL-B2GP1 (IGM, IGG, IGA) AND EL-B2GP1SCR
K Number: K972790
·
Decision Dec 5, 1997
Classifications
1
FEI Numbers
19
Registration Numbers
19
Same Product Code
45
Applicant Total
22
Review Days
130
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- THE THERATEST EL-B2GP1 (IGM, IGG, IGA) AND EL-B2GP1SCR
- K Number
- K972790
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.5660
- Medical Specialty
- Immunology
- Decision
- Substantially Equivalent
- Statement or Summary
- Statement
- Applicant
- Theratest Laboratories, Inc.
- Date Received
- July 28, 1997
- Decision Date
- December 5, 1997
- Product Code
- MSV
- Advisory Committee
- Immunology
- Review Advisory Committee
- IM
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MSV | System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) | FDA class 2 | Immunology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (MSV), ordered by most recent decision date.
Aptiva APS IgA Reagent
FDA 510(k)
FDA Class 2
·Immunology
EliA B2-Glycoprotein I IgA Immunoassay, EliA Cardiolipin IgA Immunoassay
FDA 510(k)
FDA Class 2
·Immunology
ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enhanced B2GP1 IgA/IgG/IgM Antibody ELISA
FDA 510(k)
FDA Class 2
·Immunology
QUANTA Flash B2GP1-Domain1, QUANTA Flash B2GP1-Domain1 Controls, HemosIL AcuStar Anti-B2GPI Domain 1, HemosIL AcuStar Anti-B2GPI Domain 1 Controls
FDA 510(k)
FDA Class 2
·Immunology
QUANTA FLASH ¿2GP1-DOMAIN1; CONTROLS, HEMOSIL ACUSTAR ANTI-¿2GPI DOMAIN1; CONTROLS.
FDA 510(k)
FDA Class 2
·Immunology
ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAY
FDA 510(k)
FDA Class 2
·Immunology
Other Clearances by Theratest Laboratories, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K090753 | THERATEST EL-ANTI-CCP/2 | Mar 5, 2010 | Substantially Equivalent |
| K090760 | THERATEST EL-ANTI-TPO AND THERATEST EL-ANTI-THYROGLOBULIN, MODEL 104-119, 103-120 | Sep 3, 2009 | Substantially Equivalent |
| K071692 | THERATEST EL-TTG IGA/IGG AND THERATEST EL-GLIA IGA/IGG TEST SYSTEMS | Nov 5, 2007 | Substantially Equivalent |
| K061376 | EL-ANCA: ANTI-MPO, ANTI-PR3, ANTI-MPO AND ANTI-PR3 | Jul 20, 2006 | Substantially Equivalent |
| K060176 | EL-ACL SCREEN; EL-ACL IGM, IGG, IGA | Feb 7, 2006 | Substantially Equivalent |
| K051066 | THERATEST EL-ANA PROFILES | Oct 7, 2005 | Substantially Equivalent |
| K040291 | EL-ANA PROFILES: ANTI-CHROMATIN | Mar 11, 2004 | Substantially Equivalent |
| K024031 | THE THERATEST EL-ANA PROFILES: ANTI-CENTROMERE | Feb 6, 2003 | Substantially Equivalent |
| K024151 | EL-ANA PROFILES: ANTI-RIBOSOMAL PROTEIN P | Feb 6, 2003 | Substantially Equivalent |
| K002559 | EL-ANA PROFILES-2K1 | Sep 12, 2000 | Substantially Equivalent |